We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$99.9M
2
UBER icon
Uber
UBER
+$71M
3
AVGO icon
Broadcom
AVGO
+$36.2M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$32.6M
5
LULU icon
lululemon athletica
LULU
+$32.3M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$139M
2
AAPL icon
Apple
AAPL
+$72.7M
3
VMW
VMware, Inc
VMW
+$47.1M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$42.3M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$35.5M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAI
3676
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$2.16K ﹤0.01%
337
-35
-9% -$198
DAVE icon
3677
Dave Inc
DAVE
$4.06B
$2.13K ﹤0.01%
254
– –
HKD
3678
AMTD Digital
HKD
$534M
$2.08K ﹤0.01%
500
+90
+22% +$410
ASYS icon
3679
Amtech Systems
ASYS
$272M
$2.07K ﹤0.01%
492
– –
CTMX icon
3680
CytomX Therapeutics
CTMX
$753M
$2K ﹤0.01%
1,291
– –
VERU icon
3681
Veru
VERU
$37.4M
$2K ﹤0.01%
278
– –
EVAX
3682
Evaxion A/S
EVAX
$25.9M
$2K ﹤0.01%
58
+16
+38% +$642
ASMB icon
3683
Assembly Biosciences
ASMB
$529M
$1.97K ﹤0.01%
200
– –
UP icon
3684
Wheels Up
UP
$198M
$1.94K ﹤0.01%
28
– –
BWEN icon
3685
Broadwind
BWEN
$109M
$1.94K ﹤0.01%
700
– –
PHX
3686
DELISTED
PHX Minerals
PHX
$1.93K ﹤0.01%
600
– –
LNSR icon
3687
LENSAR
LNSR
$74.2M
$1.88K ﹤0.01%
537
– –
CMCM
3688
Cheetah Mobile
CMCM
$96.5M
$1.86K ﹤0.01%
816
– –
NCTY
3689
The9 Ltd
NCTY
$71.9M
$1.85K ﹤0.01%
247
– –
CRIS icon
3690
Curis
CRIS
$7.83M
$1.84K ﹤0.01%
7
– –
APLT
3691
DELISTED
Applied Therapeutics
APLT
$1.82K ﹤0.01%
544
– –
DIBS icon
3692
1stdibs.com
DIBS
$171M
$1.71K ﹤0.01%
366
– –
CPTN
3693
DELISTED
Cepton, Inc. Common Stock
CPTN
$1.7K ﹤0.01%
541
– –
TECX
3694
Tectonic Therapeutic
TECX
$585M
$1.64K ﹤0.01%
101
– –
PRST
3695
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$1.64K ﹤0.01%
3,099
– –
CRON
3696
Cronos Group
CRON
$1.14B
$1.64K ﹤0.01%
785
– –
PXLW icon
3697
Pixelworks
PXLW
$41.6M
$1.64K ﹤0.01%
104
– –
NAII icon
3698
Natural Alternatives International
NAII
$14.9M
$1.62K ﹤0.01%
252
– –
BPYPM
3699
Brookfield Property Partners 6.25% Class A Cumulative Redeemable Preferred Units Series 1
BPYPM
$1.55K ﹤0.01%
125
– –
LYRA
3700
DELISTED
LYRA THERAPEUTICS INC
LYRA
$1.55K ﹤0.01%
6
– –
146 147
148
149 150

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.